APA (7th ed.) Citation

File, T. M., Garau, J., Jacobs, M. R., Wynne, B., Twynholm, M., & Berkowitz, E. (2005). Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains. International Journal of Antimicrobial Agents, 25(2), 110. https://doi.org/10.1016/j.ijantimicag.2004.10.007

Chicago Style (17th ed.) Citation

File, Thomas M., Javier Garau, Michael R. Jacobs, Brian Wynne, Monique Twynholm, and Elchonon Berkowitz. "Efficacy of a New Pharmacokinetically Enhanced Formulation of Amoxicillin/clavulanate (2000/125mg) in Adults with Community-acquired Pneumonia Caused by Streptococcus Pneumoniae, Including Penicillin-resistant Strains." International Journal of Antimicrobial Agents 25, no. 2 (2005): 110. https://doi.org/10.1016/j.ijantimicag.2004.10.007.

MLA (9th ed.) Citation

File, Thomas M., et al. "Efficacy of a New Pharmacokinetically Enhanced Formulation of Amoxicillin/clavulanate (2000/125mg) in Adults with Community-acquired Pneumonia Caused by Streptococcus Pneumoniae, Including Penicillin-resistant Strains." International Journal of Antimicrobial Agents, vol. 25, no. 2, 2005, p. 110, https://doi.org/10.1016/j.ijantimicag.2004.10.007.